Insmed Incorporated
RTW Investments Boosts Cogent Biosciences Stake in Q1 2026
RTW Investments significantly increased its position in biotech firm Cogent Biosciences in early 2026, signaling strong conviction ahead of potential regulatory milestones for its lead drug candidate.
Source: IndexBox Mar 22, 2026
This New $193 Million Bet Targets a Biotech With $689 Million in Revenue and a Potential Turnaround Story
This biotech firm develops therapies for rare, complement-driven diseases, with a focus on autoimmune and inflammatory conditions.
Source: Motley Fool Mar 21, 2026
This $116 Million Buy Joins a 360% Stock Run and Seemingly Signals Conviction in a Key Drug Launch
Cogent Biosciences develops targeted therapies for genetically defined diseases, focusing on precision medicine for rare cancers.
Source: Motley Fool Mar 21, 2026
How Insmed (INSM) Is Rewriting Its Story Around Brinsupri And 2026 Expectations
Insmed’s fair value estimate has been fine tuned, with the modeled price target edging from US$212.53 to US$213.00, signaling only a very modest shift in the equity story. That small adjustment lines up with recent Street commentary, where analysts are broadly constructive on Brinsupri and bronchiectasis, yet are carefully updating targets while keeping an eye on execution and sector risks. As you read on, you will see how to track these incremental changes and what they may mean for...
Source: Simply Wall St. Mar 21, 2026
RTW Investments Acquires $210M Stake in iRhythm Holdings in Q4 2025
Analysis of RTW Investments' significant $210 million stake acquisition in digital cardiac monitoring company iRhythm Holdings during the fourth quarter of 2025.
Source: IndexBox Mar 20, 2026
Integral Health Asset Management Expands Vera Therapeutics Stake in 2026
Coverage of Integral Health Asset Management's significant share purchase in Vera Therapeutics in early 2026, detailing the transaction's value and the biotech company's upcoming regulatory milestone.
Source: IndexBox Mar 20, 2026
- Adrenal Cortical Hormones
- Analgesics
- Antibiotics
- Antisera and Other Blood Fractions
- Blood-Grouping Reagents
- Diagnostic Reagents
- Immunological products, put up in measured doses
- Insulin
- Medicaments containing alkaloids or derivatives
- Medicaments containing antibiotics
- Medicaments containing hormones
- Medicaments containing penicillins or derivatives
- Medicaments containing vitamins or provitamins
- Medicinal Capsules
- Ophthalmic Medicines
- Sterile surgical catgut, similar ster ile suture materials
- Vaccines for Human Medicine
- Wadding, gauze, bandages and similar articles
- Analgesics
- Antibiotics
- Antihistamines
- Antimalarial Drugs
- Antineoplastic and immunosuppressive medicaments
- Antivirals
- Cancer Drugs
- Erythromycin and its derivatives
- Insulin
- Insulin and its salts
- Medicaments containing hormones or steroids
- Ophthalmic Solutions
- Paracetamol (acetaminophen)
- Penicillin and its derivatives
- Steroidal Hormones
- Streptomycins and their derivatives
- Tetracyclines and their derivatives
- Vaccines for Human Medicine
- Vitamins and their derivatives
IndexBox is not affiliated with, associated with, or endorsed by this company in any way. The information provided on this page, including company details, is solely for informational purposes. IndexBox makes no representations or warranties about the accuracy or completeness of the information provided.
All data and information is provided “as is” for informational purposes only, and is not intended for trading purposes or financial, investment, tax, legal, accounting or other advice. Please consult your broker or financial representative to verify pricing before executing any trade. IndexBox is not an investment adviser, financial adviser or a securities broker. None of the data and information constitutes investment advice nor an offering, recommendation or solicitation by IndexBox to buy, sell or hold any security or financial product, and IndexBox makes no representation (and has no opinion) regarding the advisability or suitability of any investment.